Jintao Feng

Title: Jintao Feng: Innovator in Immunotherapy

Introduction

Jintao Feng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunotherapy, particularly through his innovative patent related to immune system modulation. His work focuses on enhancing the effectiveness of immune responses against diseases such as cancer.

Latest Patents

Jintao Feng holds a patent for "Lymphocytes-antigen presenting cells co-stimulators and uses thereof." This patent discloses fusion proteins that activate antigen-presenting cells (APCs) and immune effector cells, such as T cells. The fusion proteins are designed to bind to activation receptors on APCs and target co-stimulatory signaling pathways in immune effector cells. Additionally, the patent includes genetically engineered immune effector cells expressing these fusion proteins, methods for their production, and their applications in treating diseases like cancer. He has 1 patent to his name.

Career Highlights

Jintao Feng is associated with Utc Therapeutics (Shanghai) Co., Ltd., where he continues to advance his research in immunotherapy. His work has the potential to revolutionize treatment options for various diseases by harnessing the power of the immune system.

Collaborations

Jintao Feng collaborates with notable colleagues, including Yangbing Zhao and Xiaojun Liu, who contribute to his research efforts and innovations in the field.

Conclusion

Jintao Feng is a key figure in the development of novel immunotherapeutic strategies. His innovative patent and ongoing research hold promise for improving cancer treatment and enhancing immune responses.